TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT
6.1. Overview
6.2. Assays, Kits, & Reagents
6.3. Systems
7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Transcription Mediated Amplification (TMA)
7.3. Loop-mediated Isothermal Amplification (LAMP)
7.4. Strand Displacement Amplification (SDA)
7.5. Helicase-dependent Amplification (HDA)
7.6. Nucleic Acid Sequence-based Amplification (NASBA)
7.7. Nicking Enzyme Amplification Reaction (NEAR)
7.8. Single Primer Isothermal Amplification (SPIA)
7.9. Other Technologies
8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION
8.1. Overview
8.2. Disease Diagnosis
8.3. Blood Screening
8.4. Other Applications
9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER
9.1. Overview
9.2. Hospitals
9.3. Reference Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Isothermal Nucleic Acid Amplification Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Isothermal Nucleic Acid Amplification Market,
11.7. Key Developments and Growth Strategies
11.7.1. New Technology Launch/Service End-User
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. GRIFOLS, S.A. (SPAIN)
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Technologys Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Hologic, Inc. (US)
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Technologys Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Abbott Laboratories (US)
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Technologys Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Becton, Dickinson and Company (US)
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Technologys Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Meridian Bioscience (US)
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Technologys Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. EIKEN CHEMICAL CO., LTD. (JAPAN)
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Technologys Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. BioMérieux SA (France),
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Technologys Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Tecan Trading AG (Switzerland)
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Technologys Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. NEW ENGLAND BIOLABS (US)
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Technologys Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. QIAGEN N.V. (Germany)
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Technologys Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 11 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 13 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 17 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 19 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 20 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 21 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 22 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 23 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 24 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 25 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 26 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 27 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 28 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 29 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 31 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 33 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 34 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 35 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 37 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 38 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 39 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 40 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 41 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 44 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 45 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 46 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 47 ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 48 ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 49 ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 50 ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 51 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 52 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 53 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 55 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 56 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 57 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 58 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 59 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 60 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 61 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 62 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 63 AUSTRALIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 64 AUSTRALIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 65 AUSTRALIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 66 AUSTRALIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 67 SOUTH KOREA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 68 SOUTH KOREA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 69 SOUTH KOREA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 70 SOUTH KOREA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 71 REST OF ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 72 REST OF ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 73 REST OF ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 76 REST OF THE WORLD: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 77 REST OF THE WORLD: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 78 REST OF THE WORLD: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 79 MIDDLE EAST: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 80 MIDDLE EAST: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 81 MIDDLE EAST: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 82 MIDDLE EAST: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 83 AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 84 AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 85 AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 86 AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 87 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 88 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 89 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 90 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, BY END-USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET
FIGURE 4 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 6 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY END-USER, 2023
FIGURE 8 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 GRIFOLS, S.A. (SPAIN): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 GRIFOLS, S.A. (SPAIN): SWOT ANALYSIS
FIGURE 16 HOLOGIC, INC. (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 HOLOGIC, INC. (US): SWOT ANALYSIS
FIGURE 18 ABBOTT LABORATORIES (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ABBOTT LABORATORIES (US): SWOT ANALYSIS
FIGURE 20 BECTON, DICKINSON AND COMPANY (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BECTON, DICKINSON AND COMPANY (US).: SWOT ANALYSIS
FIGURE 22 MERIDIAN BIOSCIENCE (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERIDIAN BIOSCIENCE (US): SWOT ANALYSIS
FIGURE 24 EIKEN CHEMICAL CO., LTD. (JAPAN): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 EIKEN CHEMICAL CO., LTD. (JAPAN): SWOT ANALYSIS
FIGURE 26 BIOMÉRIEUX SA (FRANCE), : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 BIOMÉRIEUX SA (FRANCE), : SWOT ANALYSIS
FIGURE 28 TECAN TRADING AG (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 TECAN TRADING AG (SWITZERLAND): SWOT ANALYSIS
FIGURE 30 NEW ENGLAND BIOLABS (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 NEW ENGLAND BIOLABS (US): SWOT ANALYSIS
FIGURE 32 QIAGEN N.V. (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 QIAGEN N.V. (GERMANY): SWOT ANALYSIS
